dexmedetomidine has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Dong, Y; Liu, Y; Su, Y; Sun, W; Wang, D; Xu, L | 1 |
| Dahlman, P; Eriksson, M; Hultström, M; Lönnemark, M; Semenas, E | 1 |
1 review(s) available for dexmedetomidine and Cancer of Kidney
| Article | Year |
|---|---|
[Dexmedetomidine can not reduce the incidence of acute and chronic kidney disease after laparoscopic radical nephrectomy: a propensity score matching-based analysis].
Topics: Acute Kidney Injury; Dexmedetomidine; Humans; Incidence; Kidney Neoplasms; Laparoscopy; Nephrectomy; Propensity Score; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |
1 other study(ies) available for dexmedetomidine and Cancer of Kidney
| Article | Year |
|---|---|
Analgesic effects of dexmedetomidine and remifentanil on periprocedural pain during percutaneous ablation of renal carcinoma.
Topics: Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Dexmedetomidine; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Pain Management; Proof of Concept Study; Radiofrequency Ablation; Remifentanil | 2020 |